Skip to main content
Karolinska Development logo

Karolinska Development — Investor Relations & Filings

Ticker · KDEV ISIN · SE0002190926 LEI · 54930011ZA52NKO5W681 ST Financial and insurance activities
Open in API
Filings indexed 761 across all filing types
Latest filing 2011-05-18 Share Issue/Capital Cha…
Country SE Sweden
Listing ST KDEV

About Karolinska Development

https://www.karolinskadevelopment.com/en

Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.

Recent filings

Filing Released Lang Actions
Stabilization announcement - Karolinska Development AB share
Share Issue/Capital Change Classification · 1% confidence The document is titled "Stabilization announcement – Karolinska Development AB share" and details the conclusion of the stabilization period following an Initial Public Offering (IPO). It reports on the number of shares acquired during stabilization (1,710,000 shares) and the price ranges over specific dates. This activity—managing the share price immediately after an IPO—is a form of capital market activity related to financing and share issuance/support. While it is not a direct 'Share Issue/Capital Change' (SHA) or a general 'Capital/Financing Update' (CAP), it is a specific regulatory disclosure related to the offering process. Given the options, this type of announcement, which details transactions related to the offering structure (stabilization), fits best under 'Capital/Financing Update' (CAP) as it directly relates to the capital raised/offered. It is not an earnings release, management change, or standard regulatory filing (RNS) unless no other category fits better. Since it is a specific announcement about post-IPO share management, CAP is the most appropriate fit among the provided choices.
2011-05-18 English
Pergamum genomför kvittningsemission till ett värde av SEK 120m
Capital/Financing Update Classification · 1% confidence The document text is a press release announcing that Pergamum AB has completed a 'kvittningsemission' (set-off issue/share issue to settle debt) valued at SEK 119.6m. This transaction involves the issuance of shares to settle outstanding claims, resulting in a change in ownership percentage for Karolinska Development. This clearly falls under corporate financing activities, specifically related to capital structure changes or fundraising via debt conversion. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it directly relates to fundraising and capital structure changes.
2011-05-12 Swedish
Pergamum implements offset share issue worth SEK 120m
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces that 'Pergamum implements offset share issue worth SEK 120m'. It details the transaction where debts are offset against shares, leading to an increase in Karolinska Development's ownership percentage. This activity directly relates to changes in the company's capital structure and financing through the issuance of shares (an offset share issue). This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a general regulatory filing (RNS) because it describes a specific corporate finance action, nor is it a share repurchase (POS) as it is an issuance to settle debt.
2011-05-12 English
Axelar säkerställer finansiering för det kommande fas II-programmet i lungcancer
Capital/Financing Update Classification · 1% confidence The document is a press release dated May 11, 2011, announcing that Axelar AB has secured SEK 123m in financing to proceed with a Phase II clinical trial program for a lung cancer drug (AXL1717). It details the funding consortium, mentions recent positive Phase I/II data, and includes quotes from the CEOs of Axelar and Karolinska Development. This content—announcing a significant capital raise for development purposes—fits the definition of a Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a transcript (CT). Since it is a direct announcement of financing, CAP is the most appropriate classification.
2011-05-11 Swedish
Axelar secures funding for the coming Phase II program in lung cancer
Capital/Financing Update Classification · 1% confidence The document is a press release announcing that Axelar AB has secured SEK 123 million in funding to complete its Phase II program for a lung cancer drug (AXL1717). It details the financing, the progress of the clinical trials (Phase I/II data presentation later this year), and includes quotes from the CEOs of Axelar and Karolinska Development. This type of announcement, focusing on fundraising and clinical trial progress updates, fits best under 'Capital/Financing Update' (CAP) as the primary event is securing funding, or potentially 'Regulatory Filings' (RNS) if it were a mandatory disclosure, but the core subject is the capital injection for development. Given the explicit mention of securing funding ('Axelar secures funding for the coming Phase II program'), CAP is the most precise fit over the general RNS or ER (which is for financial results).
2011-05-11 English
Ökat antal aktier och röster i Karolinska Development
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text is a short announcement (2421 characters) in Swedish regarding a change in the total number of shares and votes following an issuance related to the company's IPO on NASDAQ OMX Stockholm. The key phrases are "Ökat antal aktier och röster" (Increased number of shares and votes) and the explicit statement of the new total share count. This directly relates to a change in the company's capital structure or share count. Based on the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category, as it covers announcements regarding new share issues or capital changes. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a dividend notice (DIV) or director dealing (DIRS).
2011-04-29 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.